ClinicalTrials.gg
Sign In

Ileus clinical trials

The registry lists 167 studies for Ileus across more than 10 countries. 23 are recruiting or about to start. 136 of them are mainly about Ileus (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28. Counting its narrower condition Intestinal Pseudo-Obstruction too: 193 studies, 29 open.

Get an email when these change. Save the Ileus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
95
Status unknown
28
Recruiting
19
Terminated
17
Not yet recruiting
3
Active, not recruiting
2

Phase

Phase 2
26
Phase 3
21
Phase 4
20
Phase 1
9
Early Phase 1
1

Where

United States
59
Turkey
15
China
13
Canada
9
Belgium
7
Spain
6

Who runs them

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (6) · Cedars-Sinai Medical Center (4) · Bausch Health Americas, Inc. (4) · Tsumura USA (4) · University Hospital, Angers (4) · Chinese University of Hong Kong (4) · KU Leuven (3) · Erzincan Military Hospital (3)

What is being tested here

Drugs under test in Ileus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ropivacaine101
Alvimopan0510
Tranexamic Acid014
Protease Inhibitor Formulation LB1148013
Methylnaltrexone013
Neostigmine002
Mosapride002
Doripenem012
Lidocaine002
Glycopyrrolate001

Drug classes tested here Local anesthetics 1 open · Opioid antagonists 4

Coming up

2phase 3 studies under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 19 Ileus studies recruiting now, 12 (63%) set no upper age limit and 4 (21%) stop at 75 or younger. 3 (16%) take children under 18. 2 (11%) are for women only and 0 (0%) for men only; 2 (11%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
102 (11%)2 (11%)
1818 (95%)16 (84%)
3017 (89%)15 (79%)
4017 (89%)15 (79%)
5016 (84%)15 (79%)
6516 (84%)15 (79%)
7516 (84%)15 (79%)
8514 (74%)14 (74%)

Across all 167 studies, recruiting or not: 19% stop at 75 or younger and 11% at 65; 12% take children; 8% are for women only and 1% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ileus studies take

Of 40 interventional studies with no phase under Ileus, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase19 mo7–53 · 40 studies—19 mo7–53 · 40 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting2

Studies

Recruiting first, then most recently updated. Showing 50 of 167. Browse all 167 → or search them.